As of 2024-12-13, the Intrinsic Value of Globus Medical Inc (GMED) is
26.88 USD. This GMED valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 82.71 USD, the upside of Globus Medical Inc is
-67.50%.
The range of the Intrinsic Value is 17.00 - 73.62 USD
26.88 USD
Intrinsic Value
GMED Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
17.00 - 73.62 |
26.88 |
-67.5% |
DCF (Growth 10y) |
21.83 - 90.45 |
33.88 |
-59.0% |
DCF (EBITDA 5y) |
27.83 - 40.15 |
33.28 |
-59.8% |
DCF (EBITDA 10y) |
34.10 - 53.22 |
42.32 |
-48.8% |
Fair Value |
2.89 - 2.89 |
2.89 |
-96.51% |
P/E |
19.94 - 42.69 |
29.55 |
-64.3% |
EV/EBITDA |
26.12 - 44.33 |
34.21 |
-58.6% |
EPV |
16.50 - 22.99 |
19.75 |
-76.1% |
DDM - Stable |
6.69 - 39.63 |
23.16 |
-72.0% |
DDM - Multi |
22.68 - 105.31 |
37.42 |
-54.8% |
GMED Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
13,117.81 |
Beta |
0.75 |
Outstanding shares (mil) |
158.60 |
Enterprise Value (mil) |
12,933.93 |
Market risk premium |
4.60% |
Cost of Equity |
7.67% |
Cost of Debt |
5.00% |
WACC |
7.56% |